wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35359369-12888F6F-E3E4-40D0-A35A-6BB9D0CA6F3D
Q35359369-12888F6F-E3E4-40D0-A35A-6BB9D0CA6F3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35359369-12888F6F-E3E4-40D0-A35A-6BB9D0CA6F3D
Emerging drugs for hepatitis B.
P2860
Q35359369-12888F6F-E3E4-40D0-A35A-6BB9D0CA6F3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35359369-12888F6F-E3E4-40D0-A35A-6BB9D0CA6F3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
074fffa6b426047dce2a76bbbac5d949cb951a97
P2860
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.